ScitoVation logo
  • Services
    • Common Problems We Solve
      • Screening and Assessing Lead Compounds
      • Understanding the Mode of Action of a Compound
      • Predicting Equivalent Dose in Humans
    • Technologies
      • Toxicogenomic or Pharmacogenomic Studies
      • PBPK Modeling
      • In vitro to in vivo extrapolation (IVIVE)
      • High Content Imaging
    • Cell Based Assays
      • Cell Cycle Assay
      • Cell Cytotoxicity and Viability
      • Integrated Stress Response Assay
      • Kinetic Proliferation Assay
      • Mitochondrial Fragmentation
    • Organ Specific
      • Liver toxicity
      • Thyroid toxicity
      • Respiratory Toxicity
    • Industries
      • Pharma
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
  • Publications
  • Tools
    • PLETHEM
    • MoAVIZ
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • News
  • Request For Quote

Blog

July 19, 2022

Implementing Mode-of-Action Investigative Toxicology into Risk Assessments Through New Alternative Approaches

Read More
July 6, 2022

Pharmacodynamics and pharmacokinetics of drugs in early life stages

Read More
June 28, 2022

In Vitro Toxicity Screening to Decrease Late Stage Preclinical Compound Attrition Rate

Read More
Featured image for “ScitoVation Senior Research Fellow receives 2022 Arnold J. Lehman Award from the Society of Toxicology.”
March 21, 2022

ScitoVation Senior Research Fellow receives 2022 Arnold J. Lehman Award from the Society of Toxicology.

Read More
October 3, 2021

Using Transcriptomic Points of Departure to Determine Compound Toxicity

Read More
Featured image for “Upcoming Book Release: Clinical Pharmacology during Pregnancy, second edition, September 24, 2021 ”
September 21, 2021

Upcoming Book Release: Clinical Pharmacology during Pregnancy, second edition, September 24, 2021 

Read More
Featured image for “New publication investigating mode of action for high-dose effects of 4-methylimidazole”
September 14, 2021

New publication investigating mode of action for high-dose effects of 4-methylimidazole

Read More
Featured image for “The Importance of using Kinetically Derived Maximum Dose (KMD)”
September 8, 2021

The Importance of using Kinetically Derived Maximum Dose (KMD)

Read More
Featured image for “Discovery of a new mechanism for genetic change: Exitron splicing implications for carcinogenesis”
August 31, 2021

Discovery of a new mechanism for genetic change: Exitron splicing implications for carcinogenesis

Read More
1 2 3 4 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2022 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Screening and Assessing Lead Compounds
      • Understanding the Mode of Action of a Compound
      • Predicting Equivalent Dose in Humans
    • Technologies
      • Toxicogenomic or Pharmacogenomic Studies
      • PBPK Modeling
      • In vitro to in vivo extrapolation (IVIVE)
      • High Content Imaging
    • Cell Based Assays
      • Cell Cycle Assay
      • Cell Cytotoxicity and Viability
      • Integrated Stress Response Assay
      • Kinetic Proliferation Assay
      • Mitochondrial Fragmentation
    • Organ Specific
      • Liver toxicity
      • Thyroid toxicity
      • Respiratory Toxicity
    • Industries
      • Pharma
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
  • Publications
  • Tools
    • PLETHEM
    • MoAVIZ
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • News
  • Request For Quote